• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国患者同步性和异时性双侧乳腺癌的预后

The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients.

作者信息

Liang Xinrui, Li Danhua, Geng Wenwen, Cao Xuchen, Xiao Chunhua

机构信息

The First Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Rd, Tianjin, 300060, People's Republic of China.

出版信息

Tumour Biol. 2013 Apr;34(2):995-1004. doi: 10.1007/s13277-012-0636-4. Epub 2013 Jan 9.

DOI:10.1007/s13277-012-0636-4
PMID:23296702
Abstract

This study was undertaken to determine the differences in the clinicopathology and survival between synchronous bilateral breast cancer (sBBC) and metachronous bilateral breast cancer (mBBC). Additionally, we analyzed the risk factors for single tumors to develop as sBBC or mBBC. Of the 190 bilateral breast cancer (BBC) cases, 84 cases were sBBC and 106 were mBBC. We defined sBBC as two tumors that developed within 12 months, while mBBC was defined as two tumors that developed over more than 12 months. The peak age of onset of the first mBBC tumors was significantly younger than that of sBBC tumors (p = 0.001). There was a higher concordance rate of ER/ER positivity and PR/PR positivity in the first and second tumors of sBBC than mBBC. The two sBBC breast cancers had relatively similar hormone conditions because of the low rate of ER and PR transformation from positive to negative or vice versa. We determined that patients who presented with extracapsular extension (p = 0.008) and ER positivity (p = 0.001) tend to have synchronous cancers, while patients with 3+ HER2 were more likely to develop metachronous tumors. The prognosis for mBBC was better than that for sBBC when the survival time of mBBC was measured from the initial observation of the first tumors.

摘要

本研究旨在确定同时性双侧乳腺癌(sBBC)和异时性双侧乳腺癌(mBBC)在临床病理及生存方面的差异。此外,我们分析了单个肿瘤发展为sBBC或mBBC的风险因素。在190例双侧乳腺癌(BBC)病例中,84例为sBBC,106例为mBBC。我们将sBBC定义为在12个月内发生的两个肿瘤,而mBBC定义为在超过12个月内发生的两个肿瘤。mBBC首个肿瘤的发病高峰年龄显著低于sBBC肿瘤(p = 0.001)。sBBC首个和第二个肿瘤中ER/ER阳性及PR/PR阳性的一致性率高于mBBC。由于ER和PR从阳性转为阴性或反之的比率较低,两个sBBC乳腺癌具有相对相似的激素状况。我们确定,出现包膜外侵犯(p = 0.008)和ER阳性(p = 0.001)的患者倾向于发生同时性癌症,而HER2为3+的患者更有可能发生异时性肿瘤。当从首个肿瘤的初始观察开始测量mBBC的生存时间时,mBBC的预后优于sBBC。

相似文献

1
The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients.中国患者同步性和异时性双侧乳腺癌的预后
Tumour Biol. 2013 Apr;34(2):995-1004. doi: 10.1007/s13277-012-0636-4. Epub 2013 Jan 9.
2
Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.双侧乳腺癌经多模态治疗后:亚洲人群临床结局的报告。
Clin Breast Cancer. 2018 Aug;18(4):e727-e737. doi: 10.1016/j.clbc.2017.11.003. Epub 2017 Nov 9.
3
Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.同步和异时双侧乳腺癌中分子亚型一致性与生存结局的关系。
Breast. 2021 Jun;57:71-79. doi: 10.1016/j.breast.2021.03.005. Epub 2021 Mar 20.
4
Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis focused on cell cycle regulation.同步性和异时性双侧乳腺癌有区别吗?一项聚焦于细胞周期调控的免疫组织化学分析。
Histol Histopathol. 2018 Jan;33(1):55-64. doi: 10.14670/HH-11-887. Epub 2017 Mar 9.
5
Bilateral breast cancer, synchronous and metachronous; differences and outcome.双侧乳腺癌,同时性和异时性;差异与结局
Breast Cancer Res Treat. 2015 Sep;153(2):277-83. doi: 10.1007/s10549-015-3538-5. Epub 2015 Aug 13.
6
Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data.双侧乳腺癌的临床病理特征及预后:一项基于中国数据的单中心队列研究
Ann Transl Med. 2022 Jul;10(13):742. doi: 10.21037/atm-21-5400.
7
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).中国双侧乳腺癌:一项 10 年单中心回顾性研究(2006-2016 年)。
Cancer Med. 2021 Sep;10(17):6089-6098. doi: 10.1002/cam4.4141. Epub 2021 Aug 4.
8
The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).单侧、双侧、同期双侧和异时双侧乳腺癌的预后比较:最近十年(2008-2018 年)研究的荟萃分析。
Cancer Med. 2019 Jun;8(6):2908-2918. doi: 10.1002/cam4.2198. Epub 2019 Apr 30.
9
Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.长期随访的同步与异时性双侧乳腺癌的特性
Asian Pac J Cancer Prev. 2015;16(12):4921-6. doi: 10.7314/apjcp.2015.16.12.4921.
10
A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.中国179例同时性和异时性双侧乳腺癌临床病理特征及预后的回顾性研究
Clin Breast Cancer. 2022 Apr;22(3):e341-e349. doi: 10.1016/j.clbc.2021.09.009. Epub 2021 Sep 29.

引用本文的文献

1
Clinical characteristics and prognostic analysis of metachronous bilateral breast carcinoma: a retrospective study based on propensity score matching.基于倾向评分匹配的回顾性研究:双侧乳腺癌异时性的临床特征与预后分析。
Clin Transl Oncol. 2024 Dec;26(12):3065-3074. doi: 10.1007/s12094-024-03528-y. Epub 2024 May 27.
2
A comparative clinicopathological and survival analysis of synchronous bilateral breast cancers.同步双侧乳腺癌的临床病理及生存比较分析
Histol Histopathol. 2022 Aug;37(8):791-802. doi: 10.14670/HH-18-449. Epub 2022 Mar 14.
3
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).

本文引用的文献

1
Medical oncology in Asia.亚洲的医学肿瘤学。
Chin Clin Oncol. 2012 Sep;1(1):2. doi: 10.3978/j.issn.2304-3865.2012.08.06.
2
Guidelines on the diagnosis and treatment of breast cancer (2011 edition).乳腺癌诊疗指南(2011年版)
Gland Surg. 2012 May;1(1):39-61. doi: 10.3978/j.issn.2227-684X.2012.04.07.
3
Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis.循环肿瘤细胞(CTC)在乳腺癌中的应用:一种用于预后和分子分析的诊断工具。
中国双侧乳腺癌:一项 10 年单中心回顾性研究(2006-2016 年)。
Cancer Med. 2021 Sep;10(17):6089-6098. doi: 10.1002/cam4.4141. Epub 2021 Aug 4.
4
Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer.同步双侧乳腺癌女性中激素受体状态与BRCA1/2突变的一致性
Front Oncol. 2020 Feb 11;10:27. doi: 10.3389/fonc.2020.00027. eCollection 2020.
5
The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).单侧、双侧、同期双侧和异时双侧乳腺癌的预后比较:最近十年(2008-2018 年)研究的荟萃分析。
Cancer Med. 2019 Jun;8(6):2908-2918. doi: 10.1002/cam4.2198. Epub 2019 Apr 30.
6
Comparative genomic analysis reveals bilateral breast cancers are genetically independent.比较基因组分析显示双侧乳腺癌在基因上是独立的。
Oncotarget. 2015 Oct 13;6(31):31820-9. doi: 10.18632/oncotarget.5569.
7
A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors.早期同步双侧乳腺癌的临床病理研究:潜在风险因素的回顾性评估与前瞻性验证
PLoS One. 2014 Apr 15;9(4):e95185. doi: 10.1371/journal.pone.0095185. eCollection 2014.
Chin J Cancer Res. 2012 Dec;24(4):388-98. doi: 10.3978/j.issn.1000-9604.2012.11.03.
4
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.双侧乳腺癌中两种肿瘤雌激素受体模式的预后意义。
Breast Cancer Res Treat. 2012 Jul;134(2):793-800. doi: 10.1007/s10549-012-2096-3. Epub 2012 May 24.
5
Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer.比较双侧乳腺癌与单侧乳腺癌的临床病理特征和预后。
J Cancer Res Clin Oncol. 2012 Apr;138(4):705-14. doi: 10.1007/s00432-011-1141-7. Epub 2012 Jan 12.
6
Receptor changes in metachronous breast tumors--our experience of 10 years.同期性乳腺癌受体变化——我们十年的经验。
Am J Surg. 2012 Mar;203(3):405-9; discussion 409. doi: 10.1016/j.amjsurg.2011.09.010. Epub 2011 Dec 28.
7
Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.同步性和异时性双侧乳腺癌:长期单中心经验。
Med Oncol. 2012 Mar;29(1):16-24. doi: 10.1007/s12032-010-9785-8. Epub 2010 Dec 31.
8
Concordance in histological and biological parameters between first and second primary breast cancers.首次和二次原发性乳腺癌的组织学和生物学参数的一致性。
Cancer. 2011 Mar 1;117(5):907-15. doi: 10.1002/cncr.25587. Epub 2010 Oct 13.
9
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics.双侧乳腺癌:发病率、预后、生存和疾病特征分析。
Breast Cancer Res Treat. 2011 Feb;126(1):131-40. doi: 10.1007/s10549-010-1057-y. Epub 2010 Jul 28.
10
Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.放疗和化疗在对侧乳腺癌发生中的作用。
J Clin Oncol. 2008 Dec 1;26(34):5561-8. doi: 10.1200/JCO.2007.16.0192. Epub 2008 Oct 14.